Signal Transduction Pathways as Targets for Therapeutics

Nancy R. Gough^*

American Association for the Advancement of Science, Science's Signal Transduction Knowledge Environment, Washington, DC 20005.

Summary: Science's STKE sponsored a symposium at the AAAS Annual Meeting in February 2001. Five speakers addressed the signaling pathways that are modified in wide-ranging pathologies including inflammation, impotence, diabetes, obesity, and cancer. The molecular targets of signaling pathways included cell surface molecules, such as the G protein-coupled receptors (GPCRs) and receptor tyrosine kinases, and intracellular signaling components, such as phosphodiesterases (PDEs) and components of the small guanosine triphosphatase (GTPase) Ras signaling pathway. Analysis of the therapeutic strategies to impinge on these various pathways provides insight into both the potential of signaling pathways as relevant drug targets and the possible pitfalls that make complex signaling networks unpredictably difficult targets for such manipulation.

Contact information. E-mail: ngough{at}aaas.org

The editors suggest the following Related Resources on Science sites:

In Science Signaling

EDITORS' CHOICE
PHARMACOLOGY
PACAP, a New Target for Bipolar Disorder

(29 March 2005)
Sci. STKE 2005 (277), tw117. [DOI: 10.1126/stke.2772005tw117]
 |  Abstract »

EDITORS' CHOICE
GPCRS
GABA_B Is Coupled through GB2

(5 February 2002)
Sci. STKE 2002 (118), tw61. [DOI: 10.1126/stke.2002.118.tw61]
 |  Abstract »

VIRTUAL JOURNAL
A Single Subunit (GB2) Is Required for G-protein Activation by the Heterodimeric GABA_B Receptor

Béatrice Duthey, Sara Caudron, Julie Perroy, Bernhard Bettler, Laurent Fagni, Jean-Philippe Pin, and Laurent Prézeau (25 January 2002)
J. Biol. Chem. 277 (5), 3236. [DOI: 10.1074/jbc.M108900200]
 |  Abstract »  |  Full Text »  |  PDF »